The astrophysicist is using preimplantation genetic testing (PGT) to eliminate her future children’s risk of inheriting the ...

SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...

"This global study provides the first evidence that risk-reducing surgeries improve survival outcomes among young BRCA-mutation carriers with a prior history of early-onset breast cancer," said ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines under the ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing salpingo ...

Rucaparib camsylate is under clinical development by pharmaand and currently in Phase II for Endometrial Cancer.

Mathew Knowles, father of Beyoncé and Solange, shares his journey as both a music legend and a breast cancer survivor.

“The listing of Olaparib on the PBS addresses an unmet clinical need for targeted treatments for metastatic breast cancer patients who carry a BRCA gene mutation and it highlights the importance ...

Sisters Carissa and Cailyn Wulf tested positive for a mutation on the BRCA 1 gene, meaning they had between a 60 and 80 percent of developing breast cancer - compared to just a 12 percent risk for ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing salpingo ...